Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCP-20A cream for the treatment of atopic eczema
2005-001488-79Phase 2Unknown
- Sponsor
- Healthcare Product Development
- Start
- Apr 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of HCP-20A in atopic dermatitis (AD), sponsored by Healthcare Product Development. Primary endpoints: Clinical efficacy of HCP-20A in treating atopic eczema and Safety and tolerability. Status: unknown.
02
Drugs
HCP-20A
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-001488-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001488-79.